Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 30, 2020 07:30 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement

Merger to create Nasdaq-listed company focused on developing Viracta’s precision oncology pipeline targeting virus-associated malignancies Registration trial for Viracta’s lead program in...
November 16, 2020 16:05 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the third quarter ended September 30, 2020. Loss from...
November 09, 2020 07:00 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Monday, November 16th, 2020 at...
October 12, 2020 07:00 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

SOUTH SAN FRANCISCO, Calif., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced a poster presentation at the 32nd EORTC-NCI-AACR Symposium on Molecular...
September 03, 2020 07:00 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Announces Participation at Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that the Company will present at two upcoming virtual investor...
September 02, 2020 12:48 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Announces 1-for-10 Reverse Stock Split

SOUTH SAN FRANCISCO, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it has filed a Certificate of Amendment to its Amended and Restated...
August 11, 2020 16:05 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the second quarter ended June 30, 2020. Loss from...
August 04, 2020 07:00 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals to Host Conference Call on August 11th to Discuss Second Quarter 2020 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Tuesday, August 11th, 2020 at 4:30...
July 29, 2020 09:05 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Announces Pricing of $12 Million Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced the pricing of an underwritten public offering of 52,173,913 shares of its...
July 28, 2020 16:07 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Announces Proposed Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., July 28, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it intends to offer and sell, subject to market and other conditions,...